Related Experiment Video
Updated: Dec 23, 2025
07:49
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
20.7K
Summary
Tumor-infiltrating lymphocyte therapy with nivolumab is safe for stage IV non-small cell lung cancer. This combination shows early promise for treating advanced lung cancer.
Area of Science:
- Oncology
- Immunotherapy
- Clinical Trials
Background:
- Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality.
- Advanced or recurrent NSCLC has limited treatment options.
- Immunotherapy, particularly checkpoint inhibitors, has revolutionized cancer treatment.
Purpose of the Study:
- To evaluate the safety and tolerability of combining tumor-infiltrating lymphocyte (TIL) therapy with nivolumab.
- To assess the preliminary efficacy of this combination in patients with advanced NSCLC.
Main Methods:
- Phase I clinical trial design.
- Recruitment of patients with stage IV or recurrent non-small cell lung cancer.
- Administration of TIL therapy concurrently with nivolumab (anti-PD-1 antibody).
Main Results:
- The combination therapy was found to be safe and well-tolerated.
- Preliminary efficacy signals were observed in the patient cohort.
- Further investigation is warranted to confirm these findings.
Conclusions:
- TIL therapy combined with nivolumab is a feasible treatment strategy for advanced NSCLC.
- This approach demonstrates potential for improving outcomes in patients with limited options.
- Phase II trials are recommended to further validate efficacy.
Related Concept Videos
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:17The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K